IQVIA Holdings Inc
(BSP:I1QV34)
R$
300.4
0 (0%)
Market Cap: 218.09 Bil
Enterprise Value: 291.51 Bil
PE Ratio: 26.68
PB Ratio: 5.30
GF Score: 90/100 IQVIA Holdings Inc at Barclays Global Healthcare Conference Transcript
Mar 16, 2022 / 05:35PM GMT
Release Date Price:
R$283
(+2.54%)
Luke England Sergott
Barclays Bank PLC, Research Division - Research Analyst
Good afternoon, everyone. My name is Luke Sergott. I cover life sciences tools and diagnostics at Barclays. It's my pleasure to introduce, this as not Ron, it's Mike Fedock. He's the Head of FP&A from -- and former CFO of the RDS business at IQVIA; and Nick Childs. Ron was sick today. So Mike's subbing in.
Michael Fedock
IQVIA Holdings Inc. - SVP of Financial Planning and Analysis
Yes. It was hard to express my dedication to IQVIA to agree upon to South Florida on short notice, but that's the sacrifices I make for Ron and Ari.
Questions & Answers
Luke England Sergott
Barclays Bank PLC, Research Division - Research Analyst
All right. That's great. So I guess, as I've been doing with everybody else, let's just dive right into the macro here, go through -- let's start with the Ukraine-Russia invasion. Anything that you're seeing there from a demand perspective, any knock-on effects for trials, things like that?
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot